Daniel Sulmasy to Quality of Life
This is a "connection" page, showing publications Daniel Sulmasy has written about Quality of Life.
Connection Strength
0.851
-
Speaking of the value of life. Kennedy Inst Ethics J. 2011 Jun; 21(2):181-99.
Score: 0.211
-
Patients' ratings of quality and satisfaction with care at the end of life. Arch Intern Med. 2002 Oct 14; 162(18):2098-104.
Score: 0.116
-
A Spanish version of the McGill Quality of Life Questionnaire. J Palliat Care. 2002; 18(2):92-6.
Score: 0.110
-
Do the ward notes reflect the quality of end-of-life care? J Med Ethics. 1996 Dec; 22(6):344-8.
Score: 0.077
-
Symptom frequency, severity, and quality of life among persons with three disease trajectories: cancer, ALS, and CHF. Appl Nurs Res. 2015 Nov; 28(4):311-5.
Score: 0.068
-
The Spiritual Needs Assessment for Patients (SNAP): development and validation of a comprehensive instrument to assess unmet spiritual needs. J Pain Symptom Manage. 2012 Jul; 44(1):44-51.
Score: 0.056
-
The use of advance directives among patients with left ventricular assist devices. Hosp Pract (1995). 2011 Feb; 39(1):78-84.
Score: 0.051
-
Cancer patient preferences for quality and length of life. Cancer. 2008 Dec 15; 113(12):3459-66.
Score: 0.044
-
A biopsychosocial-spiritual model for the care of patients at the end of life. Gerontologist. 2002 Oct; 42 Spec No 3:24-33.
Score: 0.029
-
Death, dignity, and the theory of value. Ethical Perspect. 2002; 9(2-3):103-18.
Score: 0.027
-
Futility and the varieties of medical judgment. Theor Med. 1997 Mar-Jun; 18(1-2):63-78.
Score: 0.020
-
Symptoms and fear in heart failure patients approaching end of life: a mixed methods study. J Clin Nurs. 2015 Nov; 24(21-22):3215-23.
Score: 0.018
-
An exploration of relative health stock in advanced cancer patients. Med Decis Making. 2004 Nov-Dec; 24(6):614-24.
Score: 0.008
-
Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. J Clin Oncol. 2003 Jul 01; 21(13):2589-96.
Score: 0.008
-
The correlation between patient characteristics and expectations of benefit from Phase I clinical trials. Cancer. 2003 Jul 01; 98(1):166-75.
Score: 0.008